SCHEMBL5111314

SCHEMBL5111314

CC(C)C(=O)Nc1cc(F)cc(COc2c(Br)cc(C(=O)NCC(=O)O)cc2Br)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SENP5 Q96HI0 1/20 0.40
SENP2 Q9HC62 1/20 0.40
SENP1 Q9P0U3 1/20 0.40
KMT2A Q03164 4/20 0.39
MEN1 O00255 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.37
DHODH Q02127 2/20 0.37
MAPT P10636 2/20 0.37
THRA P10827 5/20 0.36
THRB P10828 5/20 0.36
PTGER1 P34995 1/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
KDM4E B2RXH2 1/20 0.35
GPR139 Q6DWJ6 1/20 0.35
ALDH1A1 P00352 1/20 0.34
ANPEP P15144 1/20 0.34
LNPEP Q9UIQ6 1/20 0.34
TP53 P04637 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5110128 0.90 SENP5 (0.40) SENP5SENP2SENP1KMT2AMEN1
SCHEMBL5110890 0.89 SENP5 (0.40) SENP5SENP2SENP1KMT2AMEN1
SCHEMBL5110065 0.89 SENP5 (0.40) SENP5SENP2SENP1KMT2AMEN1
SCHEMBL5116634 0.89 BRD4 (0.39) SENP5SENP2SENP1KMT2AMEN1
SCHEMBL4930828 0.89 SMN1; SMN2 (0.39) KMT2AMEN1SMN1; SMN2DHODHMAPT
SCHEMBL5111593 0.87 THRA (0.42) SENP5SENP2SENP1KMT2AMEN1
SCHEMBL5116889 0.87 SMN1; SMN2 (0.40) SENP5SENP2SENP1KMT2AMEN1
SCHEMBL4932258 0.86 SMN1; SMN2 (0.43) KMT2AMEN1SMN1; SMN2DHODHMAPT
SCHEMBL4350209 0.86 SENP5 (0.52) SENP5SENP2SENP1KMT2AMEN1
SCHEMBL5722494 0.86 THRA (0.42) SENP5SENP2SENP1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor KARO BIO AB (SE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor TSHR, TRHR, THRA SENP5 2379/4885SENP2 4509/4885SENP1 4088/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.